Trademark Search  /  ACCORD BIOPHARMA

ACCORD BIOPHARMA

● Live · Registered

U.S. federal trademark · Serial No. 98676658 · Reg. No. 7897439

Mark
ACCORD BIOPHARMA
Status
Registered
Serial Number
98676658
Registration No.
7897439
Filing Date
July 31, 2024
Registration Date
August 19, 2025
Class(es)
Class 005, Class 036, Class 041, Class 044

Owners

Accord Biopharma, Inc.
03 · Raleigh, NC, US
Accord Biopharma, Inc.
03 · Raleigh, NC, US
Accord Biopharma, Inc.
03 · Raleigh, NC, US

Goods & Services

Providing insurance information in the form of answers to questions from healthcare providers and patients about medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance; healthcare insurance administration services in the field of benefit verification services, prior authorization support and information, billing and claims processing support, and claims appeal support; providing information about healthcare insurance, patient financial assistance, and patient insurance reimbursement programs including enrollment requirements

A full line of medicated and pharmaceutical preparations, namely, pharmaceutical preparations and substances for use by humans for the prevention, treatment and management of cancer, autoimmune diseases, immunological deficiency syndromes in the nature of autoimmune diseases, and critical illnesses in the nature of immune system related diseases and disorders

Providing online non-downloadable videos featuring information regarding therapies and treatment options in the fields of oncology, immunology, and critical care

Providing healthcare and medical information; providing healthcare and medical information in the fields of oncology, immunology, critical care and biosimilars

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ACCORD BIOPHARMA" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.